Tuesday, January 08, 2008 10:59:21 AM
Date Comment
01/08/08 PR: "We engaged an additional six sales representatives during
the fourth quarter of 2007 for a total of 51 outside sales
representatives as of December 31, 2007."
11/19/07 10-Q: "We continue to add outside sales representatives with
a small increase to the total number of such representatives
since July 31, 2007."
08/17/07 10-Q: "With the goal of further accelerating our growth we
hired additional experienced sales representatives for a total of 41
outside sales representatives as of July 31, 2007 versus 10 such
representatives as of July 31, 2006."
04/17/07 10-K: "The incremental addition of 17 industry experienced sales
representatives during the second half of 2006 allowed us to increase
our market presence and increase orders in the last quarter of 2006.
We also added a dedicated NeuroMove sales representative
and began to implement an expanded NeuroMove sales program
directly to physicians and stroke centers. "
08/14/06 PR: "Zynex Medical Holdings, Inc. ZYNX has hired six new
sales representatives, bringing the total number of reps to 26.
As previously announced, ten sales reps were hired last month.
All 16 new sales professionals are highly experienced in
electrotherapy and medical technology sales. "
08/01/06 PR: "Zynex Medical Holdings, Inc. ZYNX has hired ten
additional sales representatives resulting in a doubling of
its US sales force over the past two months."
05/25/06 8-K: "Company management's goal and expectation is
that the Company will expand its sales force from the current
10 to 15 persons to approximately 100 members three years after a
potential financing. "
From the information above we can derive the following sales representative data:
Date Number of Reps
12/31/07 51
09/30/07 45
07/31/07 41
08/14/06 26
08/01/06 20
07/31/06 10
Something isn't right in one of their quotes above regarding the 07/31/06 and 08/01/06 numbers. I suspect that the 07/31/06 may actually be the 06/31/06 number. In any case you get the general idea of the progression.
They are now half way to the goal of 100 reps that they set back on 5/25/06!
Mike
Recent ZYXI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:15:17 PM
- Zynex Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:01:00 PM
- Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call • PR Newswire (US) • 02/22/2024 02:15:00 PM
- Zynex Introduces New Products • PR Newswire (US) • 02/20/2024 02:15:00 PM
- Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023 • GlobeNewswire Inc. • 02/08/2024 02:00:00 PM
- Zynex Receives FDA Clearance for its Next Generation NMES Device • PR Newswire (US) • 02/06/2024 02:15:00 PM
- Zynex Recognized in Top 25 Medical Device Companies for 2024 • PR Newswire (US) • 02/02/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 10:55:32 PM
- Zynex to Participate at the Needham Annual Growth Conference • PR Newswire (US) • 01/08/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:15:06 PM
- Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024" • PR Newswire (US) • 11/15/2023 02:15:00 PM
- Zynex Submits FDA Application for its Next Generation NMES Device • PR Newswire (US) • 11/13/2023 02:15:00 PM
- Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year • PR Newswire (US) • 11/09/2023 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:20:20 PM
- Zynex Announces Share Repurchase Program • PR Newswire (US) • 11/01/2023 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 09:20:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 09:20:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 09:20:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 10:50:12 AM
- Zynex Announces Review of Strategic Alternatives • PR Newswire (US) • 10/31/2023 10:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 09:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:05:38 PM
- Zynex Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 10/26/2023 08:01:00 PM
- Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row • PR Newswire (US) • 10/19/2023 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 11:02:24 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM